AGT and achalasia-alacrima syndrome: Klink et al. [46] have suggested that collagen-targeted nanoparticles may discriminate non-expanding and rupture-prone AAAs using molecular MR with a rupture model involving infusion of AngII and anti-transforming growth factor-β in wild type mice [127].